Holen Sie sich die Stockscreener-App
85.08
0.53%
0.45
Handel nachbörslich:
85.08
Schlusskurs vom Vortag:
$84.63
Offen:
$84.89
24-Stunden-Volumen:
244.89K
Relative Volume:
0.90
Marktkapitalisierung:
$3.68B
Einnahmen:
$1.11B
Nettoeinkommen (Verlust:
$205.95M
KGV:
20.70
EPS:
4.11
Netto-Cashflow:
$254.64M
1W Leistung:
-1.07%
1M Leistung:
+10.95%
6M Leistung:
+18.59%
1J Leistung:
+22.03%
1-Tages-Spanne:
$84.47
$85.72
1-Wochen-Bereich:
$84.00
$86.51
52-Wochen-Spanne:
$62.35
$88.36
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Firmenname
Prestige Consumer Healthcare Inc
Sektor
Telefon
(914) 524-6800
Adresse
660 WHITE PLAINS RD., TARRYTOWN, NY
Vergleichen Sie PBH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
85.08 | 3.68B | 1.11B | 205.95M | 254.64M | 4.11 |
|
ZTS
Zoetis Inc
|
165.31 | 74.02B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.15 | 45.90B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.08 | 44.64B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.23B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.57 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-09 | Herabstufung | Sidoti | Buy → Neutral |
| 2024-06-21 | Hochstufung | DA Davidson | Neutral → Buy |
| 2022-11-17 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-05-10 | Hochstufung | Jefferies | Hold → Buy |
| 2022-05-09 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-08-07 | Herabstufung | DA Davidson | Buy → Neutral |
| 2020-06-29 | Hochstufung | Sidoti | Neutral → Buy |
| 2020-04-14 | Herabstufung | Jefferies | Buy → Hold |
| 2020-04-07 | Fortgesetzt | Sidoti | Neutral |
| 2020-03-26 | Hochstufung | Jefferies | Hold → Buy |
| 2020-03-24 | Eingeleitet | Oppenheimer | Perform |
| 2020-03-19 | Hochstufung | DA Davidson | Neutral → Buy |
| 2019-01-15 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2017-12-04 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-06-02 | Hochstufung | Jefferies | Underperform → Hold |
| 2017-05-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-12-27 | Bestätigt | B. Riley & Co. | Buy |
| 2016-11-17 | Eingeleitet | Gabelli & Co | Buy |
| 2016-08-12 | Hochstufung | Sidoti | Neutral → Buy |
| 2016-03-08 | Eingeleitet | KeyBanc Capital Mkts | Overweight |
| 2016-02-05 | Eingeleitet | Piper Jaffray | Overweight |
| 2015-11-30 | Herabstufung | Jefferies | Hold → Underperform |
| 2014-04-28 | Bestätigt | B. Riley & Co. | Buy |
| 2014-04-28 | Bestätigt | Oppenheimer | Outperform |
| 2013-07-09 | Eingeleitet | B. Riley & Co. | Buy |
Alle ansehen
Prestige Consumer Healthcare Inc Aktie (PBH) Neueste Nachrichten
State of New Jersey Common Pension Fund D Sells 1,925 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Prestige Consumer Healthcare Inc. (NYSE:PBH) Shares Sold by Rhumbline Advisers - Defense World
New York State Teachers Retirement System Sells 4,000 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Prestige Consumer Healthcare Inc. (NYSE:PBH) is Rice Hall James & Associates LLC's 7th Largest Position - MarketBeat
Congress Asset Management Co. Grows Stake in Prestige Consumer Healthcare Inc. (NYSE:PBH) - MarketBeat
Prestige consumer healthcare EVP sells $959,270 in stock - MSN
(PBH) On The My Stocks Page - Stock Traders Daily
Prestige Consumer Healthcare (NYSE:PBH) Price Target Raised to $93.00 - MarketBeat
Allspring Global Investments Holdings LLC Buys 49,331 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - MarketBeat
PBH Q3 Earnings Beat Estimates, EPS View Raised, Shares Gain 14.8% - MSN
What is DA Davidson's Estimate for PBH FY2025 Earnings? - MarketBeat
Prestige consumer healthcare EVP sells $959,270 in stock By Investing.com - Investing.com Nigeria
Prestige Consumer Healthcare EVP Sells Over $959K in Company Stock - TradingView
William Blair Has Bullish Estimate for PBH FY2025 Earnings - MarketBeat
Oppenheimer Adjusts Prestige Consumer Healthcare Price Target to $93 From $87, Maintains Outperform Rating - Marketscreener.com
Choreo LLC Buys 3,249 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - MarketBeat
Yousif Capital Management LLC Sells 463 Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) - Defense World
Canaccord Genuity Group Raises Prestige Consumer Healthcare (NYSE:PBH) Price Target to $100.00 - MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) Price Target Raised to $104.00 - MarketBeat
What is DA Davidson’s Estimate for PBH FY2025 Earnings? - Defense World
Prestige Consumer Healthcare (NYSE:PBH) Releases Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat
Prestige Consumer Healthcare (NYSE:PBH) Shares Gap Up on Strong Earnings - MarketBeat
William Blair Has Bullish Forecast for PBH FY2025 Earnings - Defense World
Prestige Consumer Healthcare (NYSE:PBH) Price Target Raised to $100.00 - Defense World
Prestige Consumer Healthcare (NYSE:PBH) Updates FY 2025 Earnings Guidance - MarketBeat
Jennison Associates LLC Decreases Position in Prestige Consumer Healthcare Inc. (NYSE:PBH) - MarketBeat
Prestige Consumer Healthcare (PBH) Projected to Post Earnings on Thursday - MarketBeat
Prestige Consumer Healthcare (PBH) Reports Q3 Earnings: What Key Metrics Have to Say - MSN
Results: Prestige Consumer Healthcare Inc. Exceeded Expectations And The Consensus Has Updated Its Estimates - Simply Wall St
Earnings Beat: Prestige Consumer Healthcare Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Prestige Consumer Healthcare anticipates FY2025 EPS of $4.5 backed by debt reduction initiatives - MSN
What’s in Your Medicine Cabinet? It’s likely Prestige Consumer Healthcare (PBH) Products - TipRanks
DA Davidson lifts Prestige Brands stock target to $104 - MSN
15,524 Shares in Prestige Consumer Healthcare Inc. (NYSE:PBH) Acquired by DAVENPORT & Co LLC - MarketBeat
Finanzdaten der Prestige Consumer Healthcare Inc-Aktie (PBH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.92%
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):